What Nutriventia does

Nutriventia is a Mumbai, India-based B2B supplier of proprietary, clinically validated nutraceutical ingredients serving brand owners, finished-product manufacturers, and contract manufacturers across 27 countries. Founded in 2016 by Vishal Shah and Rajat Mittal Shah, the company has built a five-ingredient signature portfolio — TurmXTRA (water-dispersible turmeric), Prolanza/Ashwanova (sustained-release ashwagandha), Melotime (sustained-release melatonin), CaffXtend (sustained-release caffeine), and C-Fence (sustained-release vitamin C) — all powered by its proprietary E.D.G.E. (Enhanced Delivery For Greater Efficacy) multi-delivery platform comprising four modules: Dispersible Solutions, Modified Release, Gummy Ready, and Taste Masked. The platform is supported by 36 global patent applications (12 granted), 22 clinical studies, and 16 peer-reviewed publications, and underpins differentiated bioavailability and pharmacokinetic profiles versus standard commodity extracts.

The company monetizes through B2B ingredient sales (typically one-time license-style supply of granules, beadlets, and powders) combined with licensing of its E.D.G.E. technology platform to brand partners seeking differentiated delivery solutions. All pricing is quote-based and negotiated directly with customers; no public pricing exists. The go-to-market is sales-led and event-driven, with the technical sales team supporting formulation work and clinical data packages, complemented by presence at SupplySide Global, Vitafoods Asia, Hi Japan, NBJ Summit, Growth Asia Summit, and Convergence. Distribution combines direct enterprise sales with regional distributors and agents in Australia, South Korea, Japan, and selected European markets.

Nutriventia's commercial focus is concentrated in two primary customer segments: nutraceutical brand owners seeking clinically substantiated, low-dose, sustained-release ingredients for finished products (joint health, stress, sleep, immunity, sustained energy), and contract manufacturers requiring ready-to-use ingredient formats that integrate into capsule, tablet, gummy, stick pack, effervescent, and functional beverage production. Regulatory milestones include Health Canada NPN approval for Prolanza (NPN 80143653), Clean Label Project certification across the full five-ingredient portfolio, and GRAS self-affirmed status, positioning the company as a science-anchored alternative to commodity nutraceutical ingredient suppliers. The company remains privately held and founder-owned, with 101–250 employees and no disclosed institutional funding rounds.

Name

Nutriventia

Legal name

Nutriventia

Website

https://nutriventia.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

101–250 employees

Short description

Nutriventia is a Mumbai-based B2B supplier that develops five branded, clinically validated nutraceutical ingredients — TurmXTRA, Prolanza, Melotime, CaffXtend, and C-Fence — powered by its proprietary E.D.G.E. multi-delivery platform, and sells to brand owners and contract manufacturers across 27 countries.

Ownership category

akta.pro rank

Product category

Nutraceutical Ingredients

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried) (AFAJAKAL)

akta.pro secondary industries

Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin) (AFAJAKAK), Food-Grade Additives & Functional Ingredients Trading/Wholesale (AFAIAKAI), Herbal & Botanical Supplements (CRADAGAD)

Keywords

• Nutraceutical ingredients
• Sustained-release delivery
• Proprietary branded ingredients
• B2B ingredient supply
• Clinical-grade nutraceuticals

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. B2B Ingredient Sales: Nutriventia sells proprietary, clinically validated nutraceutical ingredients (TurmXTRA, Prolanza/Ashwanova, Melotime, CaffXtend, C-Fence) to brand owners, finished-product manufacturers, and contract manufacturers. Revenue is generated through ingredient sales, typically in bulk quantities (granules, beadlets, powders) for incorporation into finished supplements. Pricing is quote-based, with volumes and terms negotiated B2B.
2. Licensing of Proprietary Technology: The company licenses its E.D.G.E. technology platform and specific ingredient formulations to brand partners seeking differentiated delivery solutions. Technology licensing is combined with ingredient supply agreements and technical documentation packages.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Nutriventia develops, manufactures, and supplies proprietary branded nutraceutical ingredients (TurmXTRA, Prolanza/Ashwanova, CaffXtend, Melotime, C-Fence) to business customers. Ingredients are produced as bulk dosage forms (granules, beadlets, powders) for incorporation by brand owners, finished-product manufacturers, and contract manufacturers into capsules, tablets, gummies, stick packs, and functional beverages. Each ingredient is enabled by the proprietary E.D.G.E. multi-delivery platform, which provides sustained/controlled release, dispersibility, taste masking, and gummy-ready formats backed by clinical and patent protection.

Product overview

Nutriventia is a science-backed, tech-driven nutraceutical ingredient company offering a portfolio of five branded ingredient products powered by the proprietary E.D.G.E. (Enhanced Delivery For Greater Efficacy) technology platform. The platform provides multi-delivery capabilities including dispersible solutions, modified/sustained release, gummy-ready formulations, and taste masking. The product portfolio includes: TurmXTRA™ (turmeric for joint/skin health), Prolanza™/Ashwanova™ (ashwagandha for stress/sleep), CaffXtend™ (sustained caffeine), Melotime™ (sustained melatonin), and C-Fence™ (sustained vitamin C). Each product leverages the E.D.G.E. platform's delivery technology to enhance bioavailability and controlled release profiles.

Differentiator

Problem solved

Functional benefit

Brands

• TurmXTRA: Water-dispersible turmeric extract for joint health, muscle recovery, and skin health. Available in variants including TurmXTRA active for musculoskeletal support and TurmXTRA glow for skin health.
• Prolanza
• Melotime
• CaffXtend
• C-Fence

Products and services

• TurmXTRA active Water-dispersible turmeric extract standardized to 60% curcuminoids and validated for joint and muscle recovery; clinically proven at 250mg (150mg curcuminoids) for musculoskeletal health, with 250mg bioequivalent to 1575mg of standard 95% turmeric extract. Supplied as bulk granules/beadlets to brand owners and contract manufacturers.
• TurmXTRA glow Water-dispersible turmeric extract positioned for skin health; clinically proven at 250mg/day to reduce blemishes, even skin tone, and boost hydration. Same 250mg dose bioequivalent to 1575mg of standard turmeric extract. Supplied to brands for skin-health supplement formulations.
• Prolanza (Ashwanova) Root-only, sustained-release ashwagandha extract standardized to ≥4% USP Withanolides; clinically studied at 150mg and 300mg for stress relief, mood elevation, sleep quality, cognitive clarity, and emotional resilience. Marketed as Prolanza in most markets and Ashwanova in certain countries. Demonstrates 11.7x higher bioavailability and 3.1x longer half-life vs. standard ashwagandha; GRAS self-affirmed and Health Canada NPN 80143653 approved.
• CaffXtend 100% natural caffeine in a natural matrix delivering 12 hours of sustained energy and focus without caffeine crash or jitters; single-dose capsule or powder formulation suitable for 8-12 hours of alertness. Demonstrates 22% Tmax prolongation vs. immediate-release caffeine and no caffeine crash in clinical testing. Supplied as beadlets to brands and manufacturers.
• Melotime Sustained-release melatonin that releases 50% of dose in first hour with the remainder released hourly over 7 hours, providing 8 hours of sleep support without morning grogginess. Available in SR (capsules/tablets) and GR (gummy-compatible granules) formats. Demonstrates 5x longer half-life (5.10h vs. 1.01h) and 45% slower Tmax vs. immediate-release melatonin.
• C-Fence Sustained-release vitamin C delivering 24-hour immune support from a single 500mg dose; direct-compressible granules enabling single-step tablet manufacturing. Demonstrates 13x higher AUC and 8x higher Cmax vs. immediate-release vitamin C. GRAS ingredients with Halal- and Kosher-compliant grades available. Clean Label Project certified.

Quantifiable outcome

• Prolanza demonstrated 11.7x higher bioavailability and 3.1x longer half-life vs. standard ashwagandha extracts in pharmacokinetic study (Alluri et al., 2022)
• +6 more outcomes

Named customers12 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Ellipse AnalyticscoreOthersThird-party laboratory testing partner for Clean Label Project certification. Ellipse Analytics conducted independent testing of Nutriventia's full signature ingredient portfolio (Prolanza, CaffXtend, C-Fence, Melotime, and previously TurmXTRA) for heavy metals, 300+ pesticides including glyphosate, and plasticizers, validating compliance with Clean Label Project standards and California's Proposition 65 requirements.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• OmniActive Health Technologies: India-based B2B nutraceutical ingredient supplier (lutein, curcumin, botanical extracts) serving global brand owners with proprietary branded ingredients, closely comparable in geography, business model and customer base.
• Sabinsa: US-India headquartered supplier of patented, clinically validated botanical and nutraceutical ingredients (including ashwagandha and turmeric), competing head-to-head with Nutriventia in branded, science-backed extracts for supplement brands.
• Gencor: Ingredient supplier focused on bioavailability-enhanced branded botanicals (Libifem, Tesnor, Levagen+) sold to supplement and functional-food brands; comparable in its proprietary, clinically validated ingredient model.
• Indena: Italian manufacturer of standardized botanical extracts for the nutraceutical and pharmaceutical industries; comparable as a science-driven B2B ingredient company selling branded, patented botanical actives.
• PLT Health Solutions: US-based ingredient distributor and solution provider offering proprietary branded ingredients with clinical substantiation to supplement and functional-food brands; comparable go-to-market and customer profile.
• AIDP Inc. US-based supplier of branded, science-backed nutraceutical ingredients (cognitive, joint, sleep categories), comparable as a B2B ingredient partner serving supplement brands.
• Nutralliance: US distributor of specialty nutraceutical ingredients with a portfolio of branded, patented ingredients; comparable as a value-added ingredient partner for supplement brands.
• Bioiberica: Spanish life-science company producing bioactive ingredients for joint, mobility and immune health (e.g., mobilee, b2cool), directly comparable in condition-specific bioactive categories served to supplement brands.

Broad incumbents

• Kemin Industries: Global ingredient manufacturer with nutraceutical and human-health divisions offering encapsulated and specialty ingredients; comparable product formats but with much broader portfolio and scale.
• Kerry Group: Large global taste and nutrition company supplying functional ingredients and delivery systems to supplement and functional-food brands; comparable at the delivery-system layer but operates at significantly greater scale and breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/nutriventia
• YouTubeyoutube.com/@nutriventia
• LinkedInlinkedin.com/company/nutriventia

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nutriventia